Yahoo Web Search

Sign In
  1. More
  2. Anytime
  1. Explore more companies

Search results

  1. www.abbvie.comPharmaceutical Research & Development | AbbVie

    Oct 28, 2021 · AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.

  2. 187.51
    Add to watchlist
    +1.80 (+0.97%)
    At close: Wed. Aug 7, 2024 4:01 PM EDT · Nasdaq Real Time Price (USD) · Market closed
    Full chart
    • Open
      187.90
      High
      189.59
      Low
      185.98
    • Mkt Cap
      331.21B
      P/E (TTM)
      62.92
      Div & Yield
      6.20 & 3.31%
    • Prev. Close
      185.71
      52 Wk. Low
      135.85
      52 Wk. High
      193.91

    More about ABBV

    What analysts are saying
    Argus Published July 26 · AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban... Read more
    Top stories

    Related stocks

    More on Yahoo Finance

  3. www.abbvie.com › patients › patient-supportPatient Assistance | AbbVie

    AbbVie’s Patient Assistance Overview. AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients.

  4. finance.yahoo.com › quote › ABBVAbbVie Inc. (ABBV) Stock Price, News, Quote & History - Yahoo...

    Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.

  5. en.wikipedia.org › wiki › AbbVieAbbVie - Wikipedia

    AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue.

  6. news.abbvie.comAbbVie News Center - News

    Aug 1, 2024 · AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis.

  7. www.prnewswire.com › news-releases › abbvie-completes-acquisition-of-cerevelAbbVie Completes Acquisition of Cerevel Therapeutics - PR...

    6 days ago · AbbVie's Neuroscience portfolio consists of approved treatments in neurological conditions, including migraine, movement disorders and psychiatric disorders, along with a robust pipeline of ...

  8. www.abbvie.ca › en › our-companyAbout AbbVie - Our Company | AbbVie

    We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

  9. investors.abbvie.comInvestor Overview | AbbVie

    Investor Overview. AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives. Today, our passionate AbbVie team has approximately ~50,000 employees working together to help patients around the world.

  10. www.fool.com › earnings › call-transcriptsAbbVie (ABBV) Q2 2024 Earnings Call Transcript - The Motley Fool

    Jul 25, 2024 · AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in our forward-looking statements.

  11. www.statnews.com › 2024/08/02 › biotech-news-biogen-modern-abbvie-fdaThe Readout: Biogen, Moderna, AbbVie biotech news - STAT

    6 days ago · Today's biotech news updates include immunotherapy for soft-tissue cancer, AbbVie closing its Cerevel acquisition, and more.

  1. Related searches

    abbvie careersabbott laboratories
    abbvie stock pricemyabbvie assist login
    abbvie productsabbvie patient assistance
  2. People also search for